Skip to main content

Table 6 Serum urate in median and inter-quartile range (IQR) at baseline (BL) and after weight loss at 6 months (M6), 12 months (M12) and 24 months (M24) in women and men with psoriatic arthritis and obesity

From: Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity: a prospective intervention study with two years of follow-up

S-urate μmol/L BL M6 M12 M24 BL-M6
p-value
BL-M12
p-value
BL-M24
p-value
All patients 330 (280–400)
N = 39
301 (244–356)
N = 39
306 (250–348)
N = 39
324 (264–351)
N = 35
0.001 0.001 0.005
Women 309 (269–361)
N = 25
259 (232–350)
N = 25
286 (242–348)
N = 25
294 (234–338)
N = 21
0.023 0.053 0.033
Men 394 (324–416)
N = 14
324 (304–367)
N = 14
319 (294–357)
N = 14
334 (306–368)
N = 14
0.017 0.003 0.064
All controls 350 (283–384)
N = 39
280 (243–356)
N = 39
306 (267–352)
N = 39
N.A. < 0.001 0.001 N.A.
Women 309 (278–366)
N = 29
266 (230–299)
N = 29
283 (235–321)
N = 29
N.A. 0.001 0.002 N.A.
Men 400 (355–461)
N = 10
359 (332–436)
N = 10
372 (339–445)
N = 10
N.A. 0.214 0.139 N.A.